Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration

Files in This Item:
 File SizeFormat
DownloadSwanRevised_AIDSCare.pdf140.23 kBAdobe PDF
Title: Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration
Authors: Swan, DavinaLong, JeanCarr, OliviaLambert, JohnCullen, Walteret al.
Permanent link: http://hdl.handle.net/10197/9379
Date: 7-Dec-2010
Online since: 2018-05-14T09:47:54Z
Abstract: Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, particularly HCV treatment, is suboptimal. There has been little in-depth study of IDUs experiences of what enables or prevents them engaging at every level of HCV care, including testing, follow-up, management and treatment processes. This qualitative study aimed to explore these issues with current and former IDUs in the greater Dublin area, Ireland. From September 2007 to September 2008 in-depth interviews were conducted with 36 service-users across a range of primary and secondary care services, including: two addiction clinics, a general practice, a community drop-in center, two hepatology clinics, and an infectious diseases clinic. Interviews were analyzed using a grounded theory approach. Barriers to HCV care included perceptions of HCV infection as relatively benign, fear of investigations and treatment, and feeling well. Perceptions were shaped by the discourse about HCV and "horror stories'' about the liver biopsy and treatment within their peer networks. Difficulties accessing HCV care included limited knowledge of testing sites, not being referred for specialist investigations and ineligibility for treatment. Employment, education, and addiction were priorities that competed with HCV care. Relationships with health care providers influenced engagement with care: Trust in providers, concern for the service-user, and continuity of care fostered engagement. Education on HCV infection, investigations, and treatment altered perceptions. Becoming symptomatic, responsibilities for children, and wanting to move on from drug use motivated HCV treatment. In conclusion, IDUs face multiple barriers to HCV care. A range of facilitators were identified that could inform future interventions.
Funding Details: Health Research Board
Type of material: Journal Article
Publisher: Mary Ann Liebert
Journal: AIDS Patient Care and STDs
Volume: 24
Issue: 12
Start page: 753
End page: 762
Copyright (published version): 2010 Mary Ann Liebert Publications
Keywords: HCV infectionWomenRiskHIVPrevalence
DOI: 10.1089/apc.2010.0142
Language: en
Status of Item: Peer reviewed
This item is made available under a Creative Commons License: https://creativecommons.org/licenses/by-nc-nd/3.0/ie/
Appears in Collections:Medicine Research Collection

Show full item record

SCOPUSTM   
Citations 1

140
Last Week
1
Last month
0
checked on Sep 12, 2020

Page view(s)

763
Last Week
3
Last month
15
checked on Jun 24, 2021

Download(s) 50

520
checked on Jun 24, 2021

Google ScholarTM

Check

Altmetric


If you are a publisher or author and have copyright concerns for any item, please email research.repository@ucd.ie and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.